Bernardo Kracer1, Susan R Hintz2, Krisa P Van Meurs2, Henry C Lee3. 1. Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Palo Alto, CA. Electronic address: kracerb1@stanford.edu. 2. Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Palo Alto, CA. 3. Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Palo Alto, CA; California Perinatal Quality Care Collaborative, Stanford, CA.
Abstract
OBJECTIVE: To characterize the implementation of hypothermia for neonatal hypoxic ischemic encephalopathy (HIE) in a population-based cohort. STUDY DESIGN: Using the California Perinatal Quality Care Collaborative and California Perinatal Transport System linked 2010-2012 datasets, we categorized infants≥36 weeks' gestation with HIE as receiving hypothermia or normothermia. Sociodemographic and clinical factors were compared, and multivariable logistic regression was used to determine factors associated with hypothermia therapy. RESULTS: There were 238 reported encephalopathy cases in 2010, 280 in 2011, and 311 in 2012. Hypothermia therapy use in newborns with HIE increased from 59% to 73% across the study period, mainly occurring in newborns with mild or moderate encephalopathy. A total of 36 centers provided hypothermia and cared for 94% of infants, with the remaining 6% being cared for at one of 25 other centers. Of the centers providing hypothermia, 12 centers performed hypothermia therapy to more than 20 patients during the 3-year study period, and 24 centers cared for <20 patients receiving hypothermia. In-hospital mortality was 13%, which primarily was associated with the severity of encephalopathy. CONCLUSIONS: Our findings highlight an opportunity to explore practice-site variation and to develop quality improvement interventions to assure consistent evidence-based care of term infants with HIE and appropriate application of hypothermia therapy for eligible newborns.
OBJECTIVE: To characterize the implementation of hypothermia for neonatal hypoxic ischemicencephalopathy (HIE) in a population-based cohort. STUDY DESIGN: Using the California Perinatal Quality Care Collaborative and California Perinatal Transport System linked 2010-2012 datasets, we categorized infants≥36 weeks' gestation with HIE as receiving hypothermia or normothermia. Sociodemographic and clinical factors were compared, and multivariable logistic regression was used to determine factors associated with hypothermia therapy. RESULTS: There were 238 reported encephalopathy cases in 2010, 280 in 2011, and 311 in 2012. Hypothermia therapy use in newborns with HIE increased from 59% to 73% across the study period, mainly occurring in newborns with mild or moderate encephalopathy. A total of 36 centers provided hypothermia and cared for 94% of infants, with the remaining 6% being cared for at one of 25 other centers. Of the centers providing hypothermia, 12 centers performed hypothermia therapy to more than 20 patients during the 3-year study period, and 24 centers cared for <20 patients receiving hypothermia. In-hospital mortality was 13%, which primarily was associated with the severity of encephalopathy. CONCLUSIONS: Our findings highlight an opportunity to explore practice-site variation and to develop quality improvement interventions to assure consistent evidence-based care of term infants with HIE and appropriate application of hypothermia therapy for eligible newborns.
Authors: A David Edwards; Peter Brocklehurst; Alistair J Gunn; Henry Halliday; Edmund Juszczak; Malcolm Levene; Brenda Strohm; Marianne Thoresen; Andrew Whitelaw; Denis Azzopardi Journal: BMJ Date: 2010-02-09
Authors: Susan E Jacobs; Marie Berg; Rod Hunt; William O Tarnow-Mordi; Terrie E Inder; Peter G Davis Journal: Cochrane Database Syst Rev Date: 2013-01-31
Authors: Denis V Azzopardi; Brenda Strohm; A David Edwards; Leigh Dyet; Henry L Halliday; Edmund Juszczak; Olga Kapellou; Malcolm Levene; Neil Marlow; Emma Porter; Marianne Thoresen; Andrew Whitelaw; Peter Brocklehurst Journal: N Engl J Med Date: 2009-10-01 Impact factor: 91.245
Authors: D Azzopardi; B Strohm; A D Edwards; H Halliday; E Juszczak; M Levene; M Thoresen; A Whitelaw; P Brocklehurst Journal: Arch Dis Child Fetal Neonatal Ed Date: 2008-12-05 Impact factor: 5.747
Authors: Peter D Gluckman; John S Wyatt; Denis Azzopardi; Roberta Ballard; A David Edwards; Donna M Ferriero; Richard A Polin; Charlene M Robertson; Marianne Thoresen; Andrew Whitelaw; Alistair J Gunn Journal: Lancet Date: 2005 Feb 19-25 Impact factor: 79.321
Authors: Rosemary D Higgins; Tonse N K Raju; Jeffrey Perlman; Denis Victor Azzopardi; Lillian R Blackmon; Reese H Clark; A David Edwards; Donna M Ferriero; Peter D Gluckman; Alistair J Gunn; Susan E Jacobs; Dorothea Jenkins Eicher; Alan H Jobe; Abbot R Laptook; Michael H LeBlanc; Charles Palmer; Seetha Shankaran; Roger F Soll; Ann R Stark; Marianne Thoresen; John Wyatt Journal: J Pediatr Date: 2006-02 Impact factor: 4.406
Authors: Caitlin E O'Brien; Polan T Santos; Ewa Kulikowicz; Michael Reyes; Raymond C Koehler; Lee J Martin; Jennifer K Lee Journal: Dev Neurosci Date: 2019-05-20 Impact factor: 2.984
Authors: Rakesh Rao; Shamik Trivedi; Zachary Vesoulis; Steve M Liao; Christopher D Smyser; Amit M Mathur Journal: J Pediatr Date: 2016-12-13 Impact factor: 4.406
Authors: C Prempunpong; L F Chalak; J Garfinkle; B Shah; V Kalra; N Rollins; R Boyle; K-A Nguyen; I Mir; A Pappas; P Montaldo; S Thayyil; P J Sánchez; S Shankaran; A R Laptook; G Sant'Anna Journal: J Perinatol Date: 2017-11-02 Impact factor: 2.521
Authors: Megan J Kirkley; Louis Boohaker; Russell Griffin; Danielle E Soranno; Jason Gien; David Askenazi; Katja M Gist Journal: Pediatr Nephrol Date: 2018-08-28 Impact factor: 3.714
Authors: Mohammad Fazel Bakhsheshi; Hadi Vafadar Moradi; Errol E Stewart; Lynn Keenliside; Ting-Yim Lee Journal: IEEE J Transl Eng Health Med Date: 2015-04-17 Impact factor: 3.316
Authors: Rakesh Rao; Shamik Trivedi; Amy Distler; Steve Liao; Zachary Vesoulis; Christopher Smyser; Amit M Mathur Journal: Am J Perinatol Date: 2019-01-04 Impact factor: 1.862